title: Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase.
abstract: Glucagon exerts positive inotropic and chronotropic effects in the heart. Like its glycogenolytic effect in liver cells, the cardiac effects of glucagon are often correlated with adenylyl cyclase stimulation. Therefore, cyclic AMP-dependent phosphorylation of L-type Ca2+ channels might be involved in the inotropic effect of glucagon. There have been no reports, however, of the effects of glucagon on the cardiac Ca2+ current (ICa). Also, the physiological effects of glucagon could involve mechanisms other than stimulation of adenylyl cyclase. Here we show that glucagon enhances ICa in frog and rat ventricular myocytes. The effect of glucagon in rats resulted from a stimulation of adenylyl cyclase. In frogs, however, the effect of glucagon on ICa was smaller and occurred at a concentration tenfold lower than in rats, and adenylyl cyclase was not modified. In addition, cAMP potentiated the effect of glucagon on ICa in frog ventricle, which correlated with the observed inhibition by glucagon of low-Km cAMP phosphodiesterase activity. Therefore, this is an example of a hormone that affects cardiac function in a similar way to a variety of synthetic cardiotonic compounds, such as milrinone and Ro-20-1724. Inhibition of phosphodiesterase activity by glucagon may be essential in animals in which glucagon increases cardiac contractility but does not effectively stimulate adenylyl cyclase.
authors.affiliation: Laboratoire de Physiologie Cellulaire Cardiaque, INSERM U-241, Université de Paris-Sud, France.
authors.forename: P F
authors.initials: PF
authors.lastname: Méry
authors.forename: V
authors.initials: V
authors.lastname: Brechler
authors.forename: C
authors.initials: C
authors.lastname: Pavoine
authors.forename: F
authors.initials: F
authors.lastname: Pecker
authors.forename: R
authors.initials: R
authors.lastname: Fischmeister
mesh_terms: D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000109:Acetylcholine / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D015220:Calcium Channels / Q000502:physiology*; D000242:Cyclic AMP / Q000096:biosynthesis / Q000494:pharmacology; D004357:Drug Synergism; D004553:Electric Conductivity; D004789:Enzyme Activation / Q000187:drug effects; D005934:Glucagon / Q000494:pharmacology*; D006321:Heart / Q000502:physiology*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D011893:Rana esculenta; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D015220:Calcium Channels; D005934:Glucagon; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D000109:Acetylcholine